BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 34637400)

  • 1. Inhibition of estrogen signaling in myeloid cells increases tumor immunity in melanoma.
    Chakraborty B; Byemerwa J; Shepherd J; Haines CN; Baldi R; Gong W; Liu W; Mukherjee D; Artham S; Lim F; Bae Y; Brueckner O; Tavares K; Wardell SE; Hanks BA; Perou CM; Chang CY; McDonnell DP
    J Clin Invest; 2021 Dec; 131(23):. PubMed ID: 34637400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of estrogen receptor signaling in suppressing the immune response to cancer.
    Rae JM; Lippman ME
    J Clin Invest; 2021 Dec; 131(24):. PubMed ID: 34907918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiestrogens in combination with immune checkpoint inhibitors in breast cancer immunotherapy.
    Márquez-Garbán DC; Deng G; Comin-Anduix B; Garcia AJ; Xing Y; Chen HW; Cheung-Lau G; Hamilton N; Jung ME; Pietras RJ
    J Steroid Biochem Mol Biol; 2019 Oct; 193():105415. PubMed ID: 31226312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the vascular endothelial growth factor receptor-1 by the monoclonal antibody D16F7 to increase the activity of immune checkpoint inhibitors against cutaneous melanoma.
    Lacal PM; Atzori MG; Ruffini F; Scimeca M; Bonanno E; Cicconi R; Mattei M; Bernardini R; D'Atri S; Tentori L; Graziani G
    Pharmacol Res; 2020 Sep; 159():104957. PubMed ID: 32485280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor blockade and radiation therapy cooperate to enhance the response of immunologically cold ER+ breast cancer to immunotherapy.
    O'Leary KA; Bates AM; Jin WJ; Burkel BM; Sriramaneni RN; Emma SE; Nystuen EJ; Sumiec EG; Ponik SM; Morris ZS; Schuler LA
    Breast Cancer Res; 2023 Jun; 25(1):68. PubMed ID: 37312163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-32γ potentiates tumor immunity in melanoma.
    Gruber T; Kremenovic M; Sadozai H; Rombini N; Baeriswyl L; Maibach F; Modlin RL; Gilliet M; von Werdt D; Hunger RE; Seyed Jafari SM; Parisi G; Abril-Rodriguez G; Ribas A; Schenk M
    JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32841222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid-Derived Suppressive Cell Expansion Promotes Melanoma Growth and Autoimmunity by Inhibiting CD40/IL27 Regulation in Macrophages.
    Valencia JC; Erwin-Cohen RA; Clavijo PE; Allen C; Sanford ME; Day CP; Hess MM; Johnson M; Yin J; Fenimore JM; Bettencourt IA; Tsuneyama K; Romero ME; Klarmann KD; Jiang P; Bae HR; McVicar DW; Merlino G; Edmondson EF; Anandasabapathy N; Young HA
    Cancer Res; 2021 Dec; 81(23):5977-5990. PubMed ID: 34642183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade.
    House IG; Savas P; Lai J; Chen AXY; Oliver AJ; Teo ZL; Todd KL; Henderson MA; Giuffrida L; Petley EV; Sek K; Mardiana S; Gide TN; Quek C; Scolyer RA; Long GV; Wilmott JS; Loi S; Darcy PK; Beavis PA
    Clin Cancer Res; 2020 Jan; 26(2):487-504. PubMed ID: 31636098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells.
    De Henau O; Rausch M; Winkler D; Campesato LF; Liu C; Cymerman DH; Budhu S; Ghosh A; Pink M; Tchaicha J; Douglas M; Tibbitts T; Sharma S; Proctor J; Kosmider N; White K; Stern H; Soglia J; Adams J; Palombella VJ; McGovern K; Kutok JL; Wolchok JD; Merghoub T
    Nature; 2016 Nov; 539(7629):443-447. PubMed ID: 27828943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SLAMF7 Signaling Reprograms T Cells toward Exhaustion in the Tumor Microenvironment.
    O'Connell P; Hyslop S; Blake MK; Godbehere S; Amalfitano A; Aldhamen YA
    J Immunol; 2021 Jan; 206(1):193-205. PubMed ID: 33288545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PDL1-positive exosomes suppress antitumor immunity by inducing tumor-specific CD8
    Chen J; Song Y; Miao F; Chen G; Zhu Y; Wu N; Pang L; Chen Z; Chen X
    Cancer Sci; 2021 Sep; 112(9):3437-3454. PubMed ID: 34152672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of MIF-CD74 Signalling on Macrophages and Dendritic Cells Restores the Antitumour Immune Response Against Metastatic Melanoma.
    Figueiredo CR; Azevedo RA; Mousdell S; Resende-Lara PT; Ireland L; Santos A; Girola N; Cunha RLOR; Schmid MC; Polonelli L; Travassos LR; Mielgo A
    Front Immunol; 2018; 9():1132. PubMed ID: 29875777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen utilization of IGF-1-R and EGF-R to signal in breast cancer cells.
    Song RX; Chen Y; Zhang Z; Bao Y; Yue W; Wang JP; Fan P; Santen RJ
    J Steroid Biochem Mol Biol; 2010 Feb; 118(4-5):219-30. PubMed ID: 19815064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regorafenib Promotes Antitumor Immunity via Inhibiting PD-L1 and IDO1 Expression in Melanoma.
    Wu RY; Kong PF; Xia LP; Huang Y; Li ZL; Tang YY; Chen YH; Li X; Senthilkumar R; Zhang HL; Sun T; Xu XL; Yu Y; Mai J; Peng XD; Yang D; Zhou LH; Feng GK; Deng R; Zhu XF
    Clin Cancer Res; 2019 Jul; 25(14):4530-4541. PubMed ID: 30940655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical treatment of all-trans retinoic acid inhibits murine melanoma partly by promoting CD8
    Yin W; Song Y; Liu Q; Wu Y; He R
    Immunology; 2017 Oct; 152(2):287-297. PubMed ID: 28556970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of DNA methylation patterns in the tumor immune microenvironment of metastatic melanoma.
    Mitra S; Lauss M; Cabrita R; Choi J; Zhang T; Isaksson K; Olsson H; Ingvar C; Carneiro A; Staaf J; Ringnér M; Nielsen K; Brown KM; Jönsson G
    Mol Oncol; 2020 May; 14(5):933-950. PubMed ID: 32147909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous Glucocorticoid Signaling Regulates CD8
    Acharya N; Madi A; Zhang H; Klapholz M; Escobar G; Dulberg S; Christian E; Ferreira M; Dixon KO; Fell G; Tooley K; Mangani D; Xia J; Singer M; Bosenberg M; Neuberg D; Rozenblatt-Rosen O; Regev A; Kuchroo VK; Anderson AC
    Immunity; 2020 Sep; 53(3):658-671.e6. PubMed ID: 32937153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor immunity is defective in T cell-specific microRNA-155-deficient mice and is rescued by immune checkpoint blockade.
    Huffaker TB; Lee SH; Tang WW; Wallace JA; Alexander M; Runtsch MC; Larsen DK; Thompson J; Ramstead AG; Voth WP; Hu R; Round JL; Williams MA; O'Connell RM
    J Biol Chem; 2017 Nov; 292(45):18530-18541. PubMed ID: 28912267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PCSK9 facilitates melanoma pathogenesis via a network regulating tumor immunity.
    Gu Y; Lin X; Dong Y; Wood G; Seidah NG; Werstuck G; Major P; Bonert M; Kapoor A; Tang D
    J Exp Clin Cancer Res; 2023 Jan; 42(1):2. PubMed ID: 36588164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined BRAF, MEK, and CDK4/6 Inhibition Depletes Intratumoral Immune-Potentiating Myeloid Populations in Melanoma.
    Lelliott EJ; Mangiola S; Ramsbottom KM; Zethoven M; Lim L; Lau PKH; Oliver AJ; Martelotto LG; Kirby L; Martin C; Patel RP; Slater A; Cullinane C; Papenfuss AT; Haynes NM; McArthur GA; Oliaro J; Sheppard KE
    Cancer Immunol Res; 2021 Feb; 9(2):136-146. PubMed ID: 33303574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.